Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
75,000
Employees75,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
75,000
Employees75,000

PFE Key Statistics

Market cap
154.72B
Market cap154.72B
Price-Earnings ratio
20.05
Price-Earnings ratio20.05
Dividend yield
6.33%
Dividend yield6.33%
Average volume
33.40M
Average volume33.40M
High today
$27.48
High today$27.48
Low today
$27.15
Low today$27.15
Open price
$27.21
Open price$27.21
Volume
21.91M
Volume21.91M
52 Week high
$28.75
52 Week high$28.75
52 Week low
$21.87
52 Week low$21.87

Stock Snapshot

As of today, Pfizer(PFE) shares are valued at $27.23. The company's market cap stands at 154.72B, with a P/E ratio of 20.05 and a dividend yield of 6.3%.

During the trading session on 2026-04-16, Pfizer(PFE) shares reached a daily high of $27.48 and a low of $27.15. At a current price of $27.23, the stock is +0.3% higher than the low and still -0.9% under the high.

Trading volume for Pfizer(PFE) stock has reached 21.91M, versus its average volume of 33.4M.

Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $28.75 and a low of $21.87.

Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $28.75 and a low of $21.87.

PFE News

TipRanks 8h
Pfizer-Backed EV-209 Trial Targets Bladder Preservation in High-Need Cancer Segment

Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions...

TipRanks 15h
Pfizer initiated with an Outperform at CICC

CICC initiated coverage of Pfizer (PFE) with an Outperform rating and $33 price target Unlock hedge fund-level data and powerful investing tools for smarter, s...

Simply Wall St 17h
Assessing Pfizer Valuation As Investor Interest Returns And Turnaround Expectations Build

Advertisement Why Pfizer (PFE) Is Back on Investors’ Radar Pfizer (PFE) is drawing fresh attention as its share price sits near US$27.19, with recent returns...

Assessing Pfizer Valuation As Investor Interest Returns And Turnaround Expectations Build

Analyst ratings

52%

of 29 ratings
Buy
37.9%
Hold
51.7%
Sell
10.3%

More PFE News

Nasdaq 1d
What to Look for Before Buying a Pharma Stock

Key Points When researching pharma companies, investors might start by reviewing the drug pipeline. Companies constantly need to be developing their next flag...

What to Look for Before Buying a Pharma Stock
Nasdaq 2d
Investing $8,000 In Each of These 3 Stocks in 2026 Could Generate $1,500 in Annual Dividends

Key Points Investing in high-yielding dividend stocks can be risky, but the ones on this list can be gems. These stocks yield between 6.2% and 6.4%. They are...

Investing $8,000 In Each of These 3 Stocks in 2026 Could Generate $1,500 in Annual Dividends
24/7 Wall St. 2d
Build a Six Figure Dividend Stream With Four Blue Chip Names and $2 Million

Build a Six Figure Dividend Stream With Four Blue Chip Names and $2 Million By Drew Wood Published Apr 14, 9:00AM EDT Quick Read Enterprise Products Partners...

Build a Six Figure Dividend Stream With Four Blue Chip Names and $2 Million
Simply Wall St 3d
If You Believe In AI Healthcare, Then This Trio Could Shape Your Next Cycle Of Exposure

With energy shocks, higher inflation risks, and rising global bond yields keeping markets on edge, many investors are looking beyond traditional growth stories...

If You Believe In AI Healthcare, Then This Trio Could Shape Your Next Cycle Of Exposure
TipRanks 5d
Pfizer Stock Stalls As Pipeline Bets Grow

Pfizer ( (PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Easter Sale - 70% Off TipRanks Unlock hedge fund-lev...

TipRanks 6d
Pfizer told by FDA that Facebook ads for Adcetris ‘false or misleading’

In a letter to Pfizer (PFE) posted to the site of the FDA, the agency stated: “The Office of Prescription Drug Promotion of the U.S. Food and Drug Administratio...

Simply Wall St 6d
How Investors Are Reacting To Pfizer As RBC Flags Pressure On Key Drug Franchise

In recent days, RBC Capital reiterated a bearish view on Pfizer, highlighting competitive and pricing pressures on key products including Paxlovid, Vyndamax, an...

How Investors Are Reacting To Pfizer As RBC Flags Pressure On Key Drug Franchise

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.